Correlation Between Orchestra BioMed and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Protalix Biotherapeutics, you can compare the effects of market volatilities on Orchestra BioMed and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Protalix Biotherapeutics.
Diversification Opportunities for Orchestra BioMed and Protalix Biotherapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Orchestra and Protalix is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Protalix Biotherapeutics
Given the investment horizon of 90 days Orchestra BioMed Holdings is expected to under-perform the Protalix Biotherapeutics. In addition to that, Orchestra BioMed is 2.07 times more volatile than Protalix Biotherapeutics. It trades about -0.05 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.2 per unit of volatility. If you would invest 164.00 in Protalix Biotherapeutics on December 3, 2024 and sell it today you would earn a total of 67.00 from holding Protalix Biotherapeutics or generate 40.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Orchestra BioMed Holdings vs. Protalix Biotherapeutics
Performance |
Timeline |
Orchestra BioMed Holdings |
Protalix Biotherapeutics |
Orchestra BioMed and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Orchestra BioMed and Protalix Biotherapeutics
The main advantage of trading using opposite Orchestra BioMed and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.Orchestra BioMed vs. Eastman Chemical | Orchestra BioMed vs. Sealed Air | Orchestra BioMed vs. GMxico Transportes SAB | Orchestra BioMed vs. Lindblad Expeditions Holdings |
Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |